Summit Therapeutics
SMMT
#1590
Rank
A$19.62 B
Marketcap
A$26.36
Share price
-2.33%
Change (1 day)
-5.96%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: A$19.62 Billion

As of December 2025 Summit Therapeutics has a market cap of A$19.62 Billion. This makes Summit Therapeutics the world's 1590th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2025

End of year Market Cap

Year Marketcap Change
2025A$19.62 B-9.1%
2024A$21.58 B704.13%
2023A$2.68 B113.54%
2022A$1.25 B246.79%
2021A$0.36 B-27.89%
2020A$0.50 B227.52%
2019A$0.15 B471.59%
2018A$26.85 M-87.32%
2017A$0.21 B45.06%
2016A$0.14 B-24.54%
2015A$0.19 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Summit Therapeutics was reported to be:

A$19.62 Billion
by Nasdaq info icon info icon
A$19.62 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
A$3.38 B-82.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
A$9.25 B-52.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
A$0.33 B-98.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
A$0.24 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA